AI News NQ Analysis

Zeroing out 'Writing' Time for Pharmaceutical QA|AI SaaS from UTokyo Matsuo Lab's EQUES Supports Automatic Generation of Deviation Reports and Annual Reviews, Realizing DX in Quality Management

NQ Score 50/100

AI Summary (NQ-processed)

EQUES Updates QA Operations Efficiency AI SaaS 'QAI Generator'.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of the AI SaaS released by EQUES Co., Ltd. for streamlining pharmaceutical QA documentation?
A: The AI SaaS released by EQUES Co., Ltd. for streamlining documentation is named "QAI Generator".
Q: Who is the Representative Director of EQUES Co., Ltd. mentioned in the article?
A: The Representative Director of EQUES Co., Ltd. is Naoki Kishi, according to the article.
Q: Which new automatic generation functions have been added to QAI Generator in this release?
A: This release adds automatic generation functions for Deviation Reports, Quality Information Reports, and Annual Reviews.
Q: What was the first document type supported by the AI automatic generation function in the initial phase of QAI Generator?
A: In the first phase of QAI Generator, EQUES provided an AI automatic generation function for change request forms.
Q: What university lab is EQUES Co., Ltd., the developer of QAI Generator, originating from?
A: EQUES Co., Ltd. is a startup that originates from the University of Tokyo Matsuo Lab (UTokyo Matsuo Lab).